Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Same meat, different gravy: ignore the new names of mycobacteria.

Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh WJ, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ Jr, Wengenack N, van Ingen J.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900795. doi: 10.1183/13993003.00795-2019. Print 2019 Jul. No abstract available.

PMID:
31296783
2.

Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.

Kwon YS, Daley CL, Koh WJ.

Expert Rev Respir Med. 2019 Jul 8:1-11. doi: 10.1080/17476348.2019.1638765. [Epub ahead of print]

PMID:
31256694
3.

In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.

Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00665-19. doi: 10.1128/AAC.00665-19. Print 2019 Aug.

PMID:
31182533
4.

GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00516-19. doi: 10.1128/JCM.00516-19. Print 2019 Aug.

PMID:
31167842
5.

Nontuberculous Mycobacterial Musculoskeletal Infection Cases from a Tertiary Referral Center, Colorado, USA.

Goldstein N, St Clair JB, Kasperbauer SH, Daley CL, Lindeque B.

Emerg Infect Dis. 2019 Jun;25(6):1075-1083. doi: 10.3201/eid2406.181041.

6.

Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.

Moon SM, Jhun BW, Baek SY, Kim S, Jeon K, Ko RE, Shin SH, Lee H, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.

Respir Med. 2019 May;151:1-7. doi: 10.1016/j.rmed.2019.03.014. Epub 2019 Mar 26.

PMID:
31047103
7.

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.

Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL.

Eur Respir J. 2019 Jul 18;54(1). pii: 1801896. doi: 10.1183/13993003.01896-2018. Print 2019 Jul.

PMID:
31000676
8.

The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.

Eden E, Choate R, Barker A, Addrizzo-Harris D, Aksamit TR, Daley CL, Daniels MLA, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Turino GM, Winthrop KL.

Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):145-153. doi: 10.15326/jcopdf.6.2.2018.0156. Epub 2019 Apr 9.

9.

Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women.

Holt MR, Kasperbauer SH, Koelsch TL, Daley CL.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900252. doi: 10.1183/13993003.00252-2019. Print 2019 Jul. No abstract available.

PMID:
30956208
10.

Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates.

Kim SY, Moon SM, Jhun BW, Kwon OJ, Huh HJ, Lee NY, Lee SH, Shin SJ, Kasperbauer SH, Huitt GA, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02331-18. doi: 10.1128/AAC.02331-18. Print 2019 Jun.

PMID:
30885902
11.

M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.

Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, Jhun BW, Koh WJ, Namkoong H, Park J, Thomson R, van Ingen J, Zweijpfenning SMH, Yim JJ.

Eur Respir J. 2019 Jul 11;54(1). pii: 1801991. doi: 10.1183/13993003.01991-2018. Print 2019 Jul.

PMID:
30880280
12.

Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.

Moon SM, Choe J, Jhun BW, Jeon K, Kwon OJ, Huh HJ, Lee NY, Daley CL, Koh WJ.

Respir Med. 2019 Mar;148:37-42. doi: 10.1016/j.rmed.2019.01.012. Epub 2019 Jan 30.

PMID:
30827472
13.

Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.

Moon SM, Jhun BW, Daley CL, Koh WJ.

Eur Respir J. 2019 May 23;53(5). pii: 1801636. doi: 10.1183/13993003.01636-2018. Print 2019 May. No abstract available.

PMID:
30819812
14.

Genomic Analysis of Cardiac Surgery-Associated Mycobacterium chimaera Infections, United States.

Hasan NA, Epperson LE, Lawsin A, Rodger RR, Perkins KM, Halpin AL, Perry KA, Moulton-Meissner H, Diekema DJ, Crist MB, Perz JF, Salfinger M, Daley CL, Strong M.

Emerg Infect Dis. 2019 Mar;25(3):559-563. doi: 10.3201/eid2503.181282.

15.

Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.

Kim SY, Jhun BW, Moon SM, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2019 May;94(1):38-40. doi: 10.1016/j.diagmicrobio.2018.10.022. Epub 2018 Nov 30.

PMID:
30581010
16.

Treatment of Mycobacterium avium Complex Pulmonary Disease.

Kwon YS, Koh WJ, Daley CL.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):15-26. doi: 10.4046/trd.2018.0060. Review.

17.

Nontuberculous Mycobacterial Infections in Cystic Fibrosis.

Martiniano SL, Nick JA, Daley CL.

Thorac Surg Clin. 2019 Feb;29(1):95-108. doi: 10.1016/j.thorsurg.2018.09.008. Review.

PMID:
30454926
18.

The Global Fight Against Tuberculosis.

Daley CL.

Thorac Surg Clin. 2019 Feb;29(1):19-25. doi: 10.1016/j.thorsurg.2018.09.010. Review.

PMID:
30454918
19.

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. No abstract available.

PMID:
30428263
20.

Mycobacterium chimaera Infections Related to the Heater-Cooler Unit Outbreak: A Guide to Diagnosis and Management.

Kasperbauer SH, Daley CL.

Clin Infect Dis. 2019 Mar 19;68(7):1244-1250. doi: 10.1093/cid/ciy789. Erratum in: Clin Infect Dis. 2019 Jun 18;69(1):195.

PMID:
30371755
21.

ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Daley CL, Olivier KN.

Am J Respir Crit Care Med. 2018 Oct 26. doi: 10.1164/rccm.201810-1901ED. [Epub ahead of print] No abstract available.

PMID:
30365392
22.

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Shin SH, Jhun BW, Kim SY, Choe J, Jeon K, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct.

23.

Management of Multidrug-Resistant Tuberculosis.

Daley CL, Caminero JA.

Semin Respir Crit Care Med. 2018 Jun;39(3):310-324. doi: 10.1055/s-0038-1661383. Epub 2018 Aug 2. Review.

PMID:
30071546
24.

Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014.

Henkle E, Chan B, Curtis JR, Aksamit TR, Daley CL, Winthrop KL.

Chest. 2018 Dec;154(6):1311-1320. doi: 10.1016/j.chest.2018.07.014. Epub 2018 Jul 25.

PMID:
30055168
25.

US Patient-Centered Research Priorities and Roadmap for Bronchiectasis.

Henkle E, Aksamit TR, Daley CL, Griffith DE, O'Donnell AE, Quittner AL, Malanga E, Prieto D, Leitman A, Winthrop KL.

Chest. 2018 Nov;154(5):1016-1023. doi: 10.1016/j.chest.2018.06.032. Epub 2018 Jul 5.

PMID:
29981718
26.

Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates.

Kim SY, Jhun BW, Moon SM, Shin SH, Jeon K, Kwon OJ, Yoo IY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Suh GY, Koh WJ.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00527-18. doi: 10.1128/AAC.00527-18. Print 2018 Sep.

27.

Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.

Jhun BW, Kim SY, Moon SM, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1322-1330. doi: 10.1164/rccm.201802-0321OC.

PMID:
29877739
28.

Mycobacterial biomaterials and resources for researchers.

Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA.

Pathog Dis. 2018 Jun 1;76(4). doi: 10.1093/femspd/fty042. Review.

29.

Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.

Jhun BW, Yang B, Moon SM, Lee H, Park HY, Jeon K, Kwon OJ, Ahn J, Moon IJ, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00011-18. doi: 10.1128/AAC.00011-18. Print 2018 Jul.

30.

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ Jr, Winthrop KL, Wagner D; for NTM-NET.

Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available.

31.

A Woman with a 15-Year History of Bronchiectasis and Recurrent Nontuberculous Mycobacterium Pulmonary Disease.

Hogan PE, Koelsch T, Daley CL, Kasperbauer SH.

Ann Am Thorac Soc. 2018 Mar;15(3):380-382. doi: 10.1513/AnnalsATS.201707-585CC. No abstract available.

PMID:
29493335
32.

The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis.

Metersky ML, Aksamit TR, Barker A, Choate R, Daley CL, Daniels LA, DiMango A, Eden E, Griffith D, Johnson M, Knowles M, O'Donnell AE, Olivier K, Salathe M, Thomashow B, Tino G, Turino G, Winthrop KL, Mannino D.

Ann Am Thorac Soc. 2018 Mar;15(3):365-370. doi: 10.1513/AnnalsATS.201706-426OC.

33.

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.

Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.

PMID:
29329759
34.

Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Jhun BW, Moon SM, Kim SY, Park HY, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01812-17. doi: 10.1128/AAC.01812-17. Print 2018 Feb.

35.

Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.

Koh WJ, Moon SM, Kim SY, Woo MA, Kim S, Jhun BW, Park HY, Jeon K, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Kim H, Kwon OJ.

Eur Respir J. 2017 Sep 27;50(3). pii: 1602503. doi: 10.1183/13993003.02503-2016. Print 2017 Sep.

36.

Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.

Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin S, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01146-17. doi: 10.1128/AAC.01146-17. Print 2017 Oct.

37.

Frequency of untreated hypogammaglobulinemia in bronchiectasis.

Ruffner MA, Aksamit TR, Thomashow B, Choate R, DiMango A, Turino GM, O'Donnell AE, Johnson MM, Olivier KN, Fennelly K, Daley CL, Winthrop KL, Metersky ML, Salathe MA, Knowles MR, Daniels MLA, Noone PG, Tino G, Griffith DE, Sullivan KE.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):83-85. doi: 10.1016/j.anai.2017.04.020. Epub 2017 May 20. No abstract available.

38.

Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.

Martiniano SL, Wagner BD, Levin A, Nick JA, Sagel SD, Daley CL.

Chest. 2017 Oct;152(4):800-809. doi: 10.1016/j.chest.2017.04.175. Epub 2017 May 5.

PMID:
28483608
39.

Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.

Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL.

Chest. 2017 Dec;152(6):1120-1127. doi: 10.1016/j.chest.2017.04.167. Epub 2017 May 5.

40.

Mycobacterium avium Complex Disease.

Daley CL.

Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0045-2017. Review.

PMID:
28429679
41.

Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.

Yang B, Jhun BW, Moon SM, Lee H, Park HY, Jeon K, Kim DH, Kim SY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02052-16. doi: 10.1128/AAC.02052-16. Print 2017 Jun.

42.

Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.

Simpson G, Zimmerman R, Shashkina E, Chen L, Richard M, Bradford CM, Dragoo GA, Saiers RL, Peloquin CA, Daley CL, Planet P, Narachenia A, Mathema B, Kreiswirth BN.

Emerg Infect Dis. 2017 Mar;23(3):513-516. doi: 10.3201/eid2303.160726. Erratum in: Emerg Infect Dis. 2017 Apr;23(4):724.

43.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.

44.

Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.

Koh WJ, Jeong BH, Kim SY, Jeon K, Park KU, Jhun BW, Lee H, Park HY, Kim DH, Huh HJ, Ki CS, Lee NY, Kim HK, Choi YS, Kim J, Lee SH, Kim CK, Shin SJ, Daley CL, Kim H, Kwon OJ.

Clin Infect Dis. 2017 Feb 1;64(3):309-316. doi: 10.1093/cid/ciw724. Epub 2016 Nov 10.

PMID:
28011608
45.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):e1-e33. doi: 10.1093/cid/ciw694. Epub 2016 Dec 8.

PMID:
27932390
46.

Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.

Aksamit TR, O'Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, Johnson M, Eden E, Griffith D, Knowles M, Metersky M, Salathe M, Thomashow B, Tino G, Turino G, Carretta B, Daley CL; Bronchiectasis Research Registry Consortium.

Chest. 2017 May;151(5):982-992. doi: 10.1016/j.chest.2016.10.055. Epub 2016 Nov 23.

47.

Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease.

Choi H, Kim SY, Lee H, Jhun BW, Park HY, Jeon K, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02189-16. doi: 10.1128/AAC.02189-16. Print 2017 Feb.

48.

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.

Olivier KN, Griffith DE, Eagle G, McGinnis JP 2nd, Micioni L, Liu K, Daley CL, Winthrop KL, Ruoss S, Addrizzo-Harris DJ, Flume PA, Dorgan D, Salathe M, Brown-Elliott BA, Gupta R, Wallace RJ Jr.

Am J Respir Crit Care Med. 2017 Mar 15;195(6):814-823. doi: 10.1164/rccm.201604-0700OC.

49.

Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery - United States.

Perkins KM, Lawsin A, Hasan NA, Strong M, Halpin AL, Rodger RR, Moulton-Meissner H, Crist MB, Schwartz S, Marders J, Daley CL, Salfinger M, Perz JF.

MMWR Morb Mortal Wkly Rep. 2016 Oct 14;65(40):1117-1118. doi: 10.15585/mmwr.mm6540a6.

50.

Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, Leitman A, Malanga E, Marras TK, Olivier KN, Prevots DR, Prieto D, Quittner AL, Skach W, Walsh JW, Winthrop KL; NTMRC Patient Advisory Panel.

Ann Am Thorac Soc. 2016 Sep;13(9):S379-84. doi: 10.1513/AnnalsATS.201605-387WS.

Supplemental Content

Loading ...
Support Center